NewAmsterdam Pharma NAMS
NASDAQ NAMS
$21.49 -0.01 (-0.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Other financing activities (2024 - 2025)

Updated

NewAmsterdam Pharma's Other financing activities was $989,000 in FY2024.

Analysis

NewAmsterdam Pharma (NAMS) Other financing activities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 NewAmsterdam Pharma 2.66 Bn 49.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -1.59 Mn
Mar 31, 2024 -989,000.00
API Access

NewAmsterdam Pharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NAMS&period=max&api_key=YOUR_API_KEY